Bioelectronics Corp (BIEL)

[DewmBoom]

$BIEL: What is Going On and What Are We Waiting For

a. Mundipharma, a 3.4 billion dollar revenue company, just made an announcement of gaining exclusive right for Actipatch distribution in Australia and New Zealand. Both countries have a population close to 30 million people. https://www.mundipharma.com.au/mundipharma-broadens-pain-management-portfolio-with-acquisition-of-innovative-physical-therapy-devices/

b. Bayer Dr. Scholl's Licensing Agreement with Biel for the patented, FDA approved, Smart Insole Technology made by Biel

c. The mother of all FDA approvals of Actipatch that includes full body muscle and joint pain for over the counter sale. We expect Biel to submit the 510K this week or next week with approval in early to mid August. Also keep an eye on RecoveryRx that may include a submittal of a 510K and the participation in the FDA innovation challenge where candidates will be selected in November

d. Lancashire Medicines Management Group (LMMG) Recommended Actipatch in its June 2018 Listing..........HUGE

Actipatch® Actipatch®
Treatment of pain in knee osteoarthritis, plantar fasciitis and sub-muscular breast surgery
Musculoskeletal system
June 2018

http://www.lancsmmg.nhs.uk/recommendations-2/

e. Never forget the UK and Swedish reimbursement, and B. Braun pre and post operation for hip and knee with expansion to Germany. Keep an eye on ALLAY and the migraines completed clinical trial. Keep an eye on a potential major deal with a US retailer.

The second half of 2018 is going to be where all the huge events are taking place. This sounds like and feel like a multi billion dollar company already.......HUGE.






Report TOS